HCA vs TECH: fair value comparison
HCA Healthcare, Inc. and Bio-Techne Corporation · Updated 2026-09-06
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, TECH currently sits closer to the top of our discount ranking. TECH carries the stronger quality grade.
| HCA | TECH | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $405.00 | $72.43 |
| 12-month range | $370.96–$532.92 | $50.79–$72.18 |
| Sector rank | #52 of 113 Healthcare | #49 of 113 Healthcare |
| Quality grade | C | A |
| Leverage | Low | Low |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Uptrend |
| DCF cross-check | Overvalued | — |
| 52-week position | The bottom quarter | The top quarter |
Full single-stock breakdowns: HCA fair value analysis · TECH fair value analysis